Monsanto Company (NYSE:MON) has received an average recommendation of “Buy” from the twenty-four brokerages that are presently covering the firm. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $118.41.
Several brokerages have issued reports on MON. Vetr upgraded Monsanto Company from a “hold” rating to a “buy” rating and set a $118.00 price objective for the company in a research report on Wednesday, March 15th. Jefferies Group LLC restated a “buy” rating and set a $128.00 target price on shares of Monsanto Company in a research report on Tuesday, March 28th. BMO Capital Markets restated a “buy” rating and set a $128.00 target price on shares of Monsanto Company in a research report on Wednesday, April 5th. Zacks Investment Research downgraded Monsanto Company from a “buy” rating to a “hold” rating in a research report on Tuesday, February 28th. Finally, Royal Bank of Canada restated a “hold” rating and set a $118.00 target price on shares of Monsanto Company in a research report on Tuesday, March 28th.
In other news, COO Brett D. Begemann sold 80,940 shares of the company’s stock in a transaction dated Monday, April 17th. The stock was sold at an average price of $116.13, for a total transaction of $9,399,562.20. Following the completion of the transaction, the chief operating officer now directly owns 148,247 shares of the company’s stock, valued at $17,215,924.11. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Hugh Grant sold 149,230 shares of the company’s stock in a transaction dated Monday, April 10th. The stock was sold at an average price of $116.15, for a total value of $17,333,064.50. Following the transaction, the chief executive officer now directly owns 390,373 shares of the company’s stock, valued at $45,341,823.95. The disclosure for this sale can be found here. Over the last three months, insiders sold 249,540 shares of company stock valued at $28,947,034. Insiders own 0.79% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of MON. First PREMIER Bank boosted its position in Monsanto Company by 4.2% in the first quarter. First PREMIER Bank now owns 901 shares of the basic materials company’s stock valued at $102,000 after buying an additional 36 shares in the last quarter. Whitnell & Co. boosted its position in Monsanto Company by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock valued at $111,000 after buying an additional 256 shares in the last quarter. Hartford Financial Management Inc. purchased a new position in Monsanto Company during the first quarter valued at $113,000. Mascoma Wealth Management LLC purchased a new position in Monsanto Company during the fourth quarter valued at $115,000. Finally, JNBA Financial Advisors boosted its position in Monsanto Company by 24.6% in the fourth quarter. JNBA Financial Advisors now owns 1,148 shares of the basic materials company’s stock valued at $121,000 after buying an additional 227 shares in the last quarter. 75.18% of the stock is owned by institutional investors.
Monsanto Company (NYSE:MON) traded down 0.19% during mid-day trading on Monday, reaching $115.50. 2,055,180 shares of the company’s stock were exchanged. The company has a market capitalization of $50.68 billion, a P/E ratio of 26.57 and a beta of 0.93. The company’s 50 day moving average price is $114.50 and its 200-day moving average price is $107.42. Monsanto Company has a 52 week low of $88.76 and a 52 week high of $116.60.
Monsanto Company (NYSE:MON) last issued its quarterly earnings data on Wednesday, April 5th. The basic materials company reported $3.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.79 by $0.40. Monsanto Company had a return on equity of 47.05% and a net margin of 11.61%. The firm earned $5.07 billion during the quarter, compared to the consensus estimate of $4.73 billion. During the same quarter in the previous year, the company posted $2.42 EPS. The business’s revenue for the quarter was up 12.0% compared to the same quarter last year. On average, equities research analysts expect that Monsanto Company will post $4.90 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, April 7th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Wednesday, April 5th. This represents a $2.16 dividend on an annualized basis and a yield of 1.87%. Monsanto Company’s payout ratio is 58.86%.
Monsanto Company Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with our FREE daily email newsletter.